Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention1: Individualised Homoeopathic Medicines: Individualized Homoeopathic Medicines will be administered in centesimal potencies, selected according to homoeopathic principles. The dose and re
Sponsors
Dr Prachi Khatri
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals with grade 1 and 2 fatty liver established by ultrasonography. 2. Both sexes of age group above 18 years and below 60 years, irrespective of their race, caste, religion & socioeconomic status. 3. Individuals with no history of alcohol or alcohol consumption less than threshold level (30 g/day for males and 20 g/day for females).
Exclusion criteria
Exclusion criteria: 1. Patients suffering from systemic illness with life threatening complications. 2. Patients with complications like liver cirrhosis, hepatocellular carcinoma, cardiac failure. 3. Patients suffering from any other chronic liver disease like hepatitis B or C. 4. Patients who are under any other treatment for the same complaint. 5. Pregnant or lactating women 6. Patients with psychiatric disease, and those with immunocompromised state. 7. Substance abuse and/or dependence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find out whether Individualised homoeopathic medicines are more effective than Chelidonium majus 3x in the management of Non Alcoholic Fatty Liver Disease.Timepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To compare the change in the grade of fatty liver on USG in participants taking individualised homoeopathic medicines vs participants taking Chelidonium majus 3x. 2. To compare the Health- related Quality of Life (HrQoL) of the participants of the two groups using the CLDQ-NAFLD scores.Timepoint: At baseline and at end of treatment | — |
Countries
India
Contacts
Public ContactDr Prachi Khatri
Dr B R Sur Homoeopathic Medical College, Hospital And Research Centre
Outcome results
None listed